COMBINATION THERAPY

Clinical trials for COMBINATION THERAPY explained in plain language.

Never miss a new study

Get alerted when new COMBINATION THERAPY trials appear

Sign up with your email to follow new studies for COMBINATION THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

New drug combo targets Tough-to-Treat lymphoma

Disease control Not yet recruiting

This early-stage study is testing a new drug called EMB-07, given in combination with other therapies, for adults with aggressive B-cell non-Hodgkin lymphoma. The main goals are to find a safe dose and see if the treatment can shrink tumors. It will enroll about 115 people, inclu…

Matched conditions: COMBINATION THERAPY

Phase: PHASE1, PHASE2 • Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd. • Aim: Disease control

Last updated Apr 02, 2026 01:12 UTC

COMBINATION THERAPY

Get alerted when new COMBINATION THERAPY trials appear

New drug combo targets Tough-to-Treat lymphoma